These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2751951)

  • 21. Letter: Predictive value of laboratory tests.
    Stewart GT
    Lancet; 1974 Oct; 2(7887):1010. PubMed ID: 4138373
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical biostatistics XXXI. On the sensitivity, specificity, and discrimination of diagnostic tests.
    Feinstein AR
    Clin Pharmacol Ther; 1975 Jan; 17(1):104-16. PubMed ID: 1122664
    [No Abstract]   [Full Text] [Related]  

  • 23. An official ATS workshop report: issues in screening for asthma in children.
    Gerald LB; Sockrider MM; Grad R; Bender BG; Boss LP; Galant SP; Gerritsen J; Joseph CL; Kaplan RM; Madden JA; Mangan JM; Redding GJ; Schmidt DK; Schwindt CD; Taggart VS; Wheeler LS; Van Hook KN; Williams PV; Yawn BP; Yuksel B;
    Proc Am Thorac Soc; 2007 May; 4(2):133-41. PubMed ID: 17494724
    [No Abstract]   [Full Text] [Related]  

  • 24. Comments on the recent clinical guidance statement on HIV screening.
    Holtgrave DR
    Ann Intern Med; 2009 Aug; 151(4):286-7; author reply 287. PubMed ID: 19687497
    [No Abstract]   [Full Text] [Related]  

  • 25. Cancer screening--benefits, harms and making an informed choice.
    Barratt AL
    Aust Fam Physician; 2006; 35(1-2):39-42. PubMed ID: 16489385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A demonstration pilot trial for colorectal cancer screening in the United Kingdom: a new concept in the introduction of healthcare strategies.
    Steele RJ; Parker R; Patnick J; Warner J; Fraser C; Mowat NA; Wilson J; Alexander FE; Paterson JG;
    J Med Screen; 2001; 8(4):197-202. PubMed ID: 11743036
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening for gynecologic cancer.
    Pretorius G
    Surg Oncol Clin N Am; 1998 Apr; 7(2):263-9. PubMed ID: 9537975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of diagnostic or screening procedures. Validity of tests, sensitivity, specificity, predictive values. Definition and indications for mass screening].
    Durand-Zaleski I; Bastuji-Garin S
    Rev Prat; 2000 May; 50(10):1155-8. PubMed ID: 10905104
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk benefit in mass screening programs for breast cancer.
    Miller AB
    Semin Oncol; 1978 Dec; 5(4):351-9. PubMed ID: 104389
    [No Abstract]   [Full Text] [Related]  

  • 30. Report of a national workshop on screening for cancer of the cervix.
    Anderson GH
    CMAJ; 1992 Apr; 146(8):1280; author reply 1280, 1284-5. PubMed ID: 1555154
    [No Abstract]   [Full Text] [Related]  

  • 31. The cost-effectiveness of cervical-vaginal rescreening.
    Raab SS
    Am J Clin Pathol; 1997 Nov; 108(5):525-36. PubMed ID: 9353091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. External quality control of cervical cytopathology: interlaboratory variability.
    Azara CZ; Manrique EJ; Alves de Souza NL; Rodrigues AR; Tavares SB; Amaral RG
    Acta Cytol; 2013; 57(6):585-90. PubMed ID: 24107687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dynamic nature of sensitivity and specificity.
    Lofgren RP
    J Gen Intern Med; 1987; 2(6):452-3. PubMed ID: 3694305
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of oral contraceptives on the results of laboratory tests.
    Miale JB; Kent JW
    Am J Obstet Gynecol; 1974 Sep; 120(2):264-72. PubMed ID: 4607186
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening for hemoglobin disorders in Thai pregnant women by England and Frazer's calculation method.
    Suwansaksri J; Wiwanitkit V; Paritpokee N
    Arch Gynecol Obstet; 2004 Dec; 270(4):211-3. PubMed ID: 13680265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sample size calculations for rescreening cytologic smears.
    Nagy GK; Collins DN; Wilson TA
    Acta Cytol; 1996; 40(3):501-5. PubMed ID: 8669186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
    Dogbe EE; Arthur F
    Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can you handle the truth (and know it when you see it)? Understanding sensitivity, specificity, predictive values, and ROC curves.
    Cotter K; Peipert JF
    J Minim Invasive Gynecol; 2005; 12(5):385-90. PubMed ID: 16213422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating Prognostic Markers Using Relative Utility Curves and Test Tradeoffs.
    Baker SG; Kramer BS
    J Clin Oncol; 2015 Aug; 33(23):2578-80. PubMed ID: 26124476
    [No Abstract]   [Full Text] [Related]  

  • 40. Perspectives on ultrafast CT.
    Adm Radiol J; 1996 Sep; 15(9):31, 33-6. PubMed ID: 10162608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.